Sign-up for our newsletter

Funding Program Application Invoice

Welcome to the 看片视频 Funding Program Application Invoice Summary Page.

Application	Evaluating the efficacy of MSI-1436 in slowing the progression and in reversing diabetic nephropathy in the BTBR ob/ob mouse (Yin, Viravuth)
Institution	Novo Biosciences
ExternalID	32307-29
Invoice Date	4/14/2021
Date Received	4/15/2021
Start Date	1/5/2021
End Date	3/26/2021
Direct Costs Funds Available	$0.02
Direct Total	$14,249.45
Indirect Total	$0.00
Direct + Indirect	$14,249.45
Uploaded Invoice	View Invoice Document